Associated Papers
Novel deletion mutation in Bruton's tyrosine kinase results in X-linked agammaglobulinemia: A case report.
Hu XM et al.
World Journal of Clinical Cases, 2020
GESPA: classifying nsSNPs to predict disease association.
Khurana JK et al.
Bmc Bioinformatics, 2015
26206375 (PubMed )
Supplement: 12859_2015_673_MOESM2_ESM.xls › Sheet1
Genome wide analysis of pathogenic SH2 domain mutations.
Lappalainen I et al.
Proteins, 2008
BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
Fiorini M et al.
Human Mutation, 2004
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
Vihinen M et al.
Frontiers in Bioscience : a Journal and Virtual Library, 2000
Structure-function effects in primary immunodeficiencies.
Korpi M et al.
Scandinavian Journal of Immunology, 2000
Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
Mattsson PT et al.
Journal of Immunology (baltimore, Md. : 1950), 2000
Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
Hashimoto S et al.
Blood, 1996
Select a paper to view details